EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Higher expression of high-mobility group box 1 in cholangiocarcinoma and association with cell growth, in vitro migration and invasion, and chemo-drug sensitivity

Arunya Jiraviriyakul, Samitanan Promchai, Chatchai Nensat, Suphakit Khutanthong, Nun Singpan, Worawat Songjang iD

Science Progress · 2025

DOI: 10.1177/00368504251362343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Progress, 2025. Verfasst von Arunya Jiraviriyakul und 5 weiteren Autor:innen. Beteiligte Einrichtung: Integrative Biomedical Research Unit (IBRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand. Hauptthemen laut MEDLINE: Cholangiocarcinoma, HMGB1 Protein, Bile Duct Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Naresuan University (NU) and the National Science, Research, and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cholangiocarcinoma is a lethal malignancy with an increasing incidence and mortality worldwide. Numerous studies have indicated that high-mobility group box 1 is associated with cancer progression. The modulation of subcellular high-mobility group box 1 expression is a major cause of chemotherapeutic drug resistance. This study aimed to demonstrate the role of high-mobility group box 1 in cholangiocarcinoma, including proving the concept of high-mobility group box 1 expression in patients with cholangiocarcinoma, cancer cell growth, migration, invasion, and the modulation of chemotherapeutic drug sensitivity in cholangiocarcinoma cells.

Methods

Twenty paraffin-embedded tissue samples were analyzed for high-mobility group box 1 expression using immunohistochemistry. High-mobility group box 1 expression was silenced in KKU-213AL5 cells through siRNA transfection, followed by in vitro assays to assess cell proliferation, migration, invasion, and drug sensitivity. Furthermore, the role of high-mobility group box 1 in regulating growth and metastasis-related signaling pathways was investigated using immunoblotting and protein–protein interaction analysis.

Results

The results showed that high-mobility group box 1 was highly expressed in cholangiocarcinoma tissues compared to adjacent tissues ( p -value < 0.001), as well as the HMGB1 expression analysis from the TCGA database. Silencing high-mobility group box 1 by siRNA transfection resulted in the reduction of cholangiocarcinoma cell growth, migration, and invasion. Interestingly, high-mobility group box 1 silencing enhanced sensitivity to Gemcitabine and Cisplatin by increasing cell cytotoxicity compared to transfection control ( p -value = 0.0002 and 0.0258, respectively). We further demonstrated that reduction of high-mobility group box 1 expression attenuates the essential signaling proteins, including Akt, Erk, and cyclin D1, which are crucial in cancer cell growth and metastasis signaling pathways.

Conclusions

This study demonstrates that high-mobility group box 1 plays a critical role in cholangiocarcinoma proliferation, migration and invasion, and may serve as a diagnostic biomarker. Targeting high-mobility group box 1 could enhance therapeutic outcomes, particularly in overcoming drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaHMGB1 ProteinBile Duct NeoplasmsHumansCell MovementCell ProliferationCell Line, TumorDrug Resistance, NeoplasmNeoplasm InvasivenessGene Expression Regulation, NeoplasticAntineoplastic AgentsFemaleDeoxycytidineSignal TransductionMaleCisplatinGemcitabine

Stichwörter der Autor:innen

HMGB1antimetastaticcholangiocarcinomacisplatingemcitabineoxaliplatin

Substanzen

HMGB1 ProteinHMGB1 protein, humanAntineoplastic AgentsDeoxycytidineCisplatinGemcitabine

Autor:innen und Institutionen

  • Integrative Biomedical Research Unit (IBRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand.
  • Department of Medical Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand.
  • Biomedical Sciences Program, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand.
  • Department of Cardio-Thoracic Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok, Thailand.
  • Department of Pathology, Faculty of Medicine, Naresuan University, Phitsanulok, Thailand.

ORCID-Profile: Worawat Songjang

Förderung

  • Naresuan University (NU) and the National Science, Research, and Innovation Fund

Zitieren

APA

Jiraviriyakul, A., Promchai, S., Nensat, C., Khutanthong, S., Singpan, N., & Songjang, W. (2025). Higher expression of high-mobility group box 1 in cholangiocarcinoma and association with cell growth, in vitro migration and invasion, and chemo-drug sensitivity. Science Progress. https://doi.org/10.1177/00368504251362343

Vancouver

Jiraviriyakul A, Promchai S, Nensat C, Khutanthong S, Singpan N, Songjang W. Higher expression of high-mobility group box 1 in cholangiocarcinoma and association with cell growth, in vitro migration and invasion, and chemo-drug sensitivity. Science Progress. 2025. doi:10.1177/00368504251362343

BibTeX
@article{Jiraviriyakul2025,
  author = {Jiraviriyakul, Arunya and Promchai, Samitanan and Nensat, Chatchai and Khutanthong, Suphakit and Singpan, Nun and Songjang, Worawat},
  title = {Higher expression of high-mobility group box 1 in cholangiocarcinoma and association with cell growth, in vitro migration and invasion, and chemo-drug sensitivity},
  journal = {Science Progress},
  year = {2025},
  doi = {10.1177/00368504251362343}
}
Kostenlos starten →